Inogen (INGN) News Today → The only AI company to buy (From Porter & Company) (Ad) Free INGN Stock Alerts $8.30 +0.19 (+2.34%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | insidertrades.comInsider Selling: Inogen, Inc. (NASDAQ:INGN) EVP Sells 10,000 Shares of StockMay 14, 2024 | marketbeat.comJason Somer Sells 10,000 Shares of Inogen, Inc. (NASDAQ:INGN) StockInogen, Inc. (NASDAQ:INGN - Get Free Report) EVP Jason Somer sold 10,000 shares of the company's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $8.56, for a total transaction of $85,600.00. Following the transaction, the executive vice president now owns 4,452 shares in the company, valued at approximately $38,109.12. The sale was disclosed in a filing with the SEC, which can be accessed through this link.May 9, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)May 9, 2024 | finance.yahoo.comEarnings Update: Here's Why Analysts Just Lifted Their Inogen, Inc. (NASDAQ:INGN) Price Target To US$7.00May 8, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comInogen (NASDAQ:INGN) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPSInogen (NASDAQ:INGN - Get Free Report) announced its quarterly earnings results on Tuesday. The medical technology company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.76) by $0.14. The business had revenue of $78.03 million for the quarter, compared to the consensus estimate of $73.67 million. Inogen had a negative return on equity of 38.98% and a negative net margin of 32.46%. The business's revenue was up 8.1% compared to the same quarter last year. During the same period last year, the business posted ($0.63) EPS.May 8, 2024 | finance.yahoo.comQ1 2024 Inogen Inc Earnings CallMay 8, 2024 | marketbeat.comInogen (NASDAQ:INGN) Price Target Raised to $7.00 at Stifel NicolausStifel Nicolaus upped their price target on shares of Inogen from $6.00 to $7.00 and gave the company a "hold" rating in a report on Wednesday.May 8, 2024 | marketbeat.comInogen's (INGN) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Inogen in a report on Wednesday.May 8, 2024 | finance.yahoo.comInogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ...May 7, 2024 | investorplace.comINGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | washingtonpost.comInogen: Q1 Earnings SnapshotMay 7, 2024 | finance.yahoo.comInogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on GrowthMay 7, 2024 | businesswire.comInogen Announces First Quarter 2024 Financial ResultsApril 30, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Stock Position Lifted by Federated Hermes Inc.Federated Hermes Inc. grew its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 347.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 265,485 shares of the medical technology company's stock after purchasing an additional 206,12April 15, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Short Interest UpdateInogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 1,690,000 shares, a drop of 9.6% from the March 15th total of 1,870,000 shares. Based on an average daily trading volume, of 616,700 shares, the short-interest ratio is presently 2.7 days.April 13, 2024 | seekingalpha.comInogen: New Management And A Major Competitor Exit Offer Some New OpportunitiesApril 10, 2024 | businesswire.comInogen to Report First Quarter 2024 Financial Results on May 7, 2024April 9, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)April 9, 2024 | marketbeat.comInogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Inogen in a report on Tuesday.March 25, 2024 | businesswire.comInogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceMarch 18, 2024 | ca.finance.yahoo.comINGN Apr 2024 10.000 callMarch 17, 2024 | finance.yahoo.comINGN Apr 2024 5.000 putMarch 17, 2024 | finance.yahoo.comINGN Apr 2024 15.000 callMarch 16, 2024 | finance.yahoo.comINGN Apr 2024 12.500 callMarch 16, 2024 | finance.yahoo.comINGN Apr 2024 7.500 putMarch 13, 2024 | finanznachrichten.deInogen Alliance: Preparing for 4 New EU Environmental Regulations in 2024March 7, 2024 | businesswire.comInogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)March 1, 2024 | marketbeat.comMeros Investment Management LP Has $3.08 Million Holdings in Inogen, Inc. (NASDAQ:INGN)Meros Investment Management LP lifted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 14.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 589,604 shares of the medical techMarch 1, 2024 | finance.yahoo.comInogen Full Year 2023 Earnings: EPS Misses ExpectationsMarch 1, 2024 | marketbeat.comQ1 2024 EPS Estimates for Inogen, Inc. (NASDAQ:INGN) Reduced by William BlairInogen, Inc. (NASDAQ:INGN - Free Report) - Investment analysts at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for shares of Inogen in a note issued to investors on Tuesday, February 27th. William Blair analyst M. Kaczor now expects that the medical technology company wiFebruary 29, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | barrons.comInogen Inc.February 28, 2024 | msn.comWhy Is Inogen Stock Plummeting Today?February 28, 2024 | marketbeat.comTrading was temporarily halted for "INGN" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 27, 2024 | finance.yahoo.comInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 | finance.yahoo.comInogen Inc (INGN) Reports Decline in 2023 Revenue and Widening Net LossFebruary 27, 2024 | businesswire.comInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 | finanznachrichten.deInogen Alliance Ranked #41 in Environment Analyst's Top 100 Global Environmental & Sustainability Consultancy Firms ReportFebruary 27, 2024 | marketbeat.comAcadian Asset Management LLC Raises Holdings in Inogen, Inc. (NASDAQ:INGN)Acadian Asset Management LLC grew its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 195.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 389,792 shares of the medical technology cFebruary 26, 2024 | markets.businessinsider.comWhat Wall Street expects from Inogen's earningsFebruary 23, 2024 | benzinga.comInogen Stock (NASDAQ:INGN), Short Interest ReportFebruary 17, 2024 | ca.finance.yahoo.comINGN Mar 2024 10.000 putFebruary 15, 2024 | markets.businessinsider.comCompetitor Exit A Boom For Respiratory Device-Focused Inogen, Earns Analyst UpgradeFebruary 15, 2024 | msn.comInogen stock rallies 22% as William Blair ups rating to outperformFebruary 15, 2024 | marketbeat.comTocqueville Asset Management L.P. Cuts Position in Inogen, Inc. (NASDAQ:INGN)Tocqueville Asset Management L.P. lessened its stake in Inogen, Inc. (NASDAQ:INGN - Free Report) by 69.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,850 shares of the medical technology company's stock afteFebruary 15, 2024 | marketbeat.comInogen (NASDAQ:INGN) Lifted to Outperform at William BlairWilliam Blair raised shares of Inogen from a "market perform" rating to an "outperform" rating in a research report on Thursday.February 14, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Short Interest Up 22.1% in JanuaryInogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,880,000 shares, an increase of 22.1% from the January 15th total of 1,540,000 shares. Based on an average trading volume of 498,300 shares, the short-interest ratio is currently 3.8 days.February 6, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $1.18 Million Stock Position in Inogen, Inc. (NASDAQ:INGN)Assenagon Asset Management S.A. raised its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 73.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 225,730 shares of the medical technology company's stock after acquiring an additional 95,913 sFebruary 5, 2024 | benzinga.comInogen Stock (NASDAQ:INGN) Dividends: History, Yield and Dates Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution INGN Media Mentions By Week INGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INGN News Sentiment▼1.430.77▲Average Medical News Sentiment INGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INGN Articles This Week▼22▲INGN Articles Average Week Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Jin Medical International News Sanara MedTech News Lakeland Industries News CollPlant Biotechnologies News Alpha Pro Tech News Nutriband News Milestone Scientific News Envoy Medical News Vicarious Surgical News ReWalk Robotics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INGN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Clinton Backing Biden Replacement???The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.